Among these, IGF2BP3 exhibits high expression in various tumor tissues, such as lung cancer [12], gastric cancer [13], pancreatic cancer [14], kidney cancer [15], hepatocellular carcinoma [16], breast cancer [17], and ovarian carcinoma [18], in contrast to adjacent normal tissues, indicating its role in promoting tumorigenesis [19]. This evidence concerns the gene IGF2BP3 and neoplasm.